Free Trial
→ With the “Bitcoin Loophole” you can help supercharge the gains by 10x or more! (From DTI) (Ad)

15 Healthcare Stocks that Analysts Love in a Post-Pandemic World - 8 of 15

Slide 8
Back to 7
Continue to 9
 
Back to 7
Continue to 9
 

Revolution Medicines (NASDAQ:RVMD)

Consensus Rating
Buy
Rating Score
3.1
Ratings Breakdown
12 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$61.00 (3.1% Upside)

About Revolution Medicines

Revolution Medicines logoRevolution Medicines, Inc, a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline comprises RAS(ON) inhibitors designed to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors for combination treatment strategies. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
11/7/2024HC WainwrightBoost Price TargetBuy ➝ Buy$62.00 ➝ $64.00
11/7/2024Needham & Company LLCBoost Price TargetBuy ➝ Buy$61.00 ➝ $68.00
11/7/2024JPMorgan Chase & Co.Boost Price TargetOverweight ➝ Overweight$54.00 ➝ $63.00
11/7/2024Piper SandlerBoost Price TargetOverweight ➝ Overweight$57.00 ➝ $70.00
10/28/2024GuggenheimBoost Price TargetBuy ➝ Buy$72.00 ➝ $82.00
10/28/2024OppenheimerBoost Price TargetOutperform ➝ Outperform$55.00 ➝ $60.00
10/24/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$61.00 ➝ $61.00
10/7/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$61.00 ➝ $61.00
9/27/2024BarclaysBoost Price TargetOverweight ➝ Overweight$54.00 ➝ $60.00
8/12/2024HC WainwrightReiterated RatingBuy ➝ Buy$56.00 ➝ $56.00
Slide 8
Back to 7
Continue to 9
 

New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar (Ad)

As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.

👉 Click here to access your FREE report now!

More From MarketBeat
Amazon's $150B Data Center Bet—What It Means for Uranium Investors
Amazon is placing a massive bet on nuclear energy to power its $150 billion data center expansion. With dem...
The Bull Report | Sponsored
7 Consumer Discretionary Stocks That Will Heat Up with Rate Cuts
As the second quarter earnings season ends, a recurring theme for many companies that rely on the discretionar...
MarketBeat
Options Trading on Bitcoin?
SEC Approves Crypto Options Trading Select altcoins poised for RAPID growth by early 2025…
Crypto 101 Media | Sponsored
7 Drone Stocks to Buy as the Technology Goes Mainstream
According to a StartUs Insights Drone Industry Report, there are over 33,000 companies in the drone industry. ...
MarketBeat
Central Bank Abandons USD
Startling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...
True Gold Republic | Sponsored
7 ETFs to Invest in Now for Maximum Returns
In the last 12 months, many investors have heard that this is a “stock picker's market." This means that...
MarketBeat